This company develops small molecule therapeutics aimed at treating age-related diseases by engineering aging medicine. They utilize an integrated platform combining optogenetics, chemistry, and AI to unravel complex biology with high precision. This approach allows for the systematic exploration of chemical space to unlock novel therapeutic opportunities.
Funding
$17.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SHFounders
Product
Problem
Age-related diseases, including neurodegeneration and cancer, are significantly influenced by cellular stress responses. Targeting these stress responses with therapeutics could modify disease progression and promote healthy aging, but identifying effective drug targets and molecules remains a challenge.
Solution
Integrated Biosciences leverages synthetic biology and machine learning to develop small molecule therapeutics that modulate cellular stress responses, addressing age-related diseases. Their proprietary synthetic biology technology enables the activation of cellular stress responses, facilitating the discovery of drugs that target stressed cells and the rapid identification of relevant drug targets. Complementing this, advanced deep learning approaches accelerate the identification of small molecules with therapeutic potential. This integrated approach aims to create disease-modifying treatments that promote healthy aging.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions focused on developing therapeutics for age-related diseases such as neurodegeneration, cancer, and cardiometabolic disorders.
Features
- Proprietary synthetic biology platform for virtually activating cellular stress responses.
- Machine learning algorithms for identifying small molecules that modulate stress pathways.
- Capability to discover drugs specifically targeting stressed cells.
- Identification of novel drug targets within cellular stress response pathways.